Controlling Lentiviruses: Single Amino Acid Changes Can Determine Specificity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Mar 11

PMID 15010528

Citations 3

Authors

Shari M Kaiser

Michael Emerman

Affiliations

Soon will be listed here.

Citing Articles

Productive Replication of HIV-1 but Not SIVmac in Small Ruminant Cells.

Chergui H, Idres T, Chaudesaigues C, Noueihed D, Gagnon J, Chebloune Y Pathogens. 2022; 11(7).

PMID: 35890043 PMC: 9316499. DOI: 10.3390/pathogens11070799.

HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis.

Williams K, Burdo T APMIS. 2009; 117(5-6):400-12.

PMID: 19400864 PMC: 2739573. DOI: 10.1111/j.1600-0463.2009.02450.x.

Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

VandeWoude S, Apetrei C Clin Microbiol Rev. 2006; 19(4):728-62.

PMID: 17041142 PMC: 1592692. DOI: 10.1128/CMR.00009-06.

References

Bogerd H, Doehle B, Wiegand H, Cullen B . A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A. 2004; 101(11):3770-4. PMC: 374319. DOI: 10.1073/pnas.0307713101. View

Sheehy A, Gaddis N, Choi J, Malim M . Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. DOI: 10.1038/nature00939. View

Sheehy A, Gaddis N, Malim M . The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 2003; 9(11):1404-7. DOI: 10.1038/nm945. View

Varthakavi V, Smith R, Bour S, Strebel K, Spearman P . Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci U S A. 2003; 100(25):15154-9. PMC: 299932. DOI: 10.1073/pnas.2433165100. View

Zhang H, Yang B, Pomerantz R, Zhang C, Arunachalam S, Gao L . The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003; 424(6944):94-8. PMC: 1350966. DOI: 10.1038/nature01707. View

Peeters M, Courgnaud V, Abela B, Auzel P, Pourrut X, Bibollet-Ruche F . Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis. 2002; 8(5):451-7. PMC: 2732488. DOI: 10.3201/eid0805.010522. View

Bieniasz P . Restriction factors: a defense against retroviral infection. Trends Microbiol. 2003; 11(6):286-91. DOI: 10.1016/s0966-842x(03)00123-9. View

Courgnaud V, Salemi M, Pourrut X, Mpoudi-Ngole E, Abela B, Auzel P . Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J Virol. 2002; 76(16):8298-309. PMC: 155126. DOI: 10.1128/jvi.76.16.8298-8309.2002. View

Lecossier D, Bouchonnet F, Clavel F, Hance A . Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 2003; 300(5622):1112. DOI: 10.1126/science.1083338. View

10.

Xu H, Svarovskaia E, Barr R, Zhang Y, Khan M, Strebel K . A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc Natl Acad Sci U S A. 2004; 101(15):5652-7. PMC: 397464. DOI: 10.1073/pnas.0400830101. View

11.

Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B . Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 2003; 114(1):21-31. DOI: 10.1016/s0092-8674(03)00515-4. View

12.

Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J . An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 2002; 79(3):285-96. DOI: 10.1006/geno.2002.6718. View

13.

Marin M, Rose K, Kozak S, Kabat D . HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med. 2003; 9(11):1398-403. DOI: 10.1038/nm946. View

14.

Stopak K, de Noronha C, Yonemoto W, Greene W . HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell. 2003; 12(3):591-601. DOI: 10.1016/s1097-2765(03)00353-8. View

15.

Bailes E, Gao F, Bibollet-Ruche F, Courgnaud V, Peeters M, Marx P . Hybrid origin of SIV in chimpanzees. Science. 2003; 300(5626):1713. DOI: 10.1126/science.1080657. View

16.

Neuberger M, Harris R, Di Noia J, Petersen-Mahrt S . Immunity through DNA deamination. Trends Biochem Sci. 2003; 28(6):305-12. DOI: 10.1016/S0968-0004(03)00111-7. View

17.

Harris R, Bishop K, Sheehy A, Craig H, Petersen-Mahrt S, Watt I . DNA deamination mediates innate immunity to retroviral infection. Cell. 2003; 113(6):803-9. DOI: 10.1016/s0092-8674(03)00423-9. View

18.

Conticello S, Harris R, Neuberger M . The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol. 2003; 13(22):2009-13. DOI: 10.1016/j.cub.2003.10.034. View

19.

Simon J, Miller D, Fouchier R, Soares M, Peden K, Malim M . The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 1998; 17(5):1259-67. PMC: 1170474. DOI: 10.1093/emboj/17.5.1259. View

20.

Hahn B, Shaw G, De Cock K, Sharp P . AIDS as a zoonosis: scientific and public health implications. Science. 2000; 287(5453):607-14. DOI: 10.1126/science.287.5453.607. View